Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Pairnomix logo — Empowering personalized healthcare through genetic insights...

Pairnomix

Empowering personalized healthcare through genetic insights and innovative treatment options for rare disease discovery and development.

Founded 2016 Health Care, Pharmaceutical

General Information

Company Name Pairnomix
Founded Year 2016
Industries Health Care, Pharmaceutical
Social

Get notified when Pairnomix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pairnomix

Pairnomix is a health care and pharmaceutical startup with a mission to utilize genetic insights and innovative treatment options for rare disease discovery and development. Established in January 2016, Pairnomix provides support to physicians and patients by offering detailed information about rare genetic mutations and suitable drug therapies. The company's specialized genetic research involves creating a model of a patient’s genetic mutation, examining its functional impacts, and testing approved drugs on the model to identify new treatment options. The results are then presented in personalized reports to the patient’s physician, facilitating better-informed healthcare decisions. Moreover, Pairnomix's insights contribute to rare disease drug discovery and development efforts, ultimately aiming to empower personalized healthcare.

Taxonomy: Genetic research, Rare diseases, Personalized healthcare, Drug discovery, Rare genetic mutations, Patient-centric treatment, Innovative therapies, Healthcare decision support, Physician support, Functional impact assessment, Approved drug testing, Healthcare insights, Data-driven treatment options, Rare disease development, Precision medicine

No funding data available for Pairnomix yet.

Get notified when Pairnomix raises funding

Pairnomix Alternatives & Competitors

Pairnomix vs
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals United States

Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat rare and u...

IPO
12 employees
Pairnomix vs
Gain Therapeutics
Gain Therapeutics United States

Unfolding the next generation of allosteric small molecule therapies to meet patient needs

IPO
26 employees
Biotechnology, Pharmaceutical
Pairnomix vs
HealthLumen
HealthLumen United Kingdom

Virtual populations. Real decisions.

13 employees
Health Care

FAQ About Pairnomix

Empowering personalized healthcare through genetic insights and innovative treatment options for rare disease discovery and development.
Pairnomix was founded in 2016.
Pairnomix operates in the following industries: Health Care, Pharmaceutical.
Top alternatives and competitors to Pairnomix include Eloxx Pharmaceuticals, Gain Therapeutics, HealthLumen, Odylia Therapeutics, Versantis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pairnomix and Eloxx Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pairnomix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy